# Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery

> **NCT00573066** · PHASE1 · COMPLETED · sponsor: **Athena Zuppa** · enrollment: 56 (actual)

## Conditions studied

- Hypoplastic Left Heart
- Tetralogy of Fallot
- Tricuspid Atresia

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT00573066
- **Lead sponsor:** Athena Zuppa
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2013-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00573066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00573066, "Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00573066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*